Internal Fixation Systems website
Internal Fixation Systems, Inc. Announces Sale of Modular Locking Small Fragment System
MIAMI, Oct. 24, 2011 /PRNewswire/ — Internal Fixation Systems, Inc. (OTC QB: IFIX) today announces that it has commenced offering for sale the initial modules (consisting of basic instruments and screws and 1/3 tubular plates) of its FDA approved small fragment system which will be used to treat bone fractures and osteotomies. “We believe our new modular set design is innovative in the industry,” said Internal Fixation Systems President and CEO, Stephen Dresnick, MD. “Rather than have large sets with multiple types of plates, our system makes more efficient use of inventory by standardizing instruments and surgical trays across product lines. This allows us to pass along greater savings to our customers and ultimately to patients.
About IFS: Internal Fixation Systems, Inc is a manufacturer and marketer of high quality, responsibly priced orthopedic and podiatric implants. We seek to prove that superior products and lower costs can go hand in hand. IFS focuses on widely used, market proven products used to treat common fractures. Our Advisory Panel, consisting of nationally recognized surgeons, provides input on how to improve our implant designs. The resulting products incorporate doctor requested enhancements and are priced at 40-60% less than the competition. IFS customers include ambulatory surgery centers, hospitals and orthopedic surgeons. Please contact us for more information about our product and business model.